Stockscreener 앱 받기
4.88
3.39%
0.16
시간 외 거래:
4.75
-0.13
-2.66%
전일 마감가:
$4.72
열려 있는:
$4.77
하루 거래량:
669.03K
Relative Volume:
0.94
시가총액:
$337.28M
수익:
-
순이익/손실:
$-89.66M
주가수익비율:
-2.0161
EPS:
-2.4205
순현금흐름:
$-81.90M
1주 성능:
-4.69%
1개월 성능:
-23.75%
6개월 성능:
-17.01%
1년 성능:
+223.18%
1일 변동 폭
$4.77
$5.10
1주일 범위
$4.50
$5.10
52주 변동 폭
$0.8801
$7.80
Pepgen Inc Stock (PEPG) Company Profile
명칭
Pepgen Inc
전화
703-456-8000
주소
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Compare PEPG vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
4.88 | 326.22M | 0 | -89.66M | -81.90M | -2.4205 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-09 | 개시 | Guggenheim | Buy |
| 2024-12-16 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-07-31 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-21 | 개시 | H.C. Wainwright | Buy |
Pepgen Inc 주식(PEPG)의 최신 뉴스
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc.PEPG - Bluefield Daily Telegraph
Value Recap: Why is PepGen Inc stock going downQuarterly Trade Report & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
If You Invested $1,000 in PepGen Inc (PEPG) - Stock Titan
Aug Patterns: What are the analyst revisions for NEOVIs PepGen Inc stock a good investment in YEAREarnings Miss & Technical Confirmation Trade Alerts - baoquankhu1.vn
PEPG Stock Price, Quote & Chart | PEPGEN INC (NASDAQ:PEPG) - ChartMill
PepGen, Inc. (NASDAQ:PEPG) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
PEPG SEC FilingsPepGen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
COMMODORE CAPITAL LP Acquires Additional Shares in PepGen Inc - GuruFocus
How much upside is left in PepGen (PEPG)? Wall Street analysts think 75.44% - MSN
Boxer Capital Management LLC Invests $1.16 Million in PepGen, Inc. $PEPG - MarketBeat
Commodore Capital LP Invests $10.89 Million in PepGen, Inc. $PEPG - MarketBeat
FDA Places Partial Hold On PepGen's Myotonic Dystrophy Drug Trial - Sahm
PepGen shares slide 20% as FDA clinical hold overshadows earnings beat - MSN
Aug Volume: Is PepGen Inc stock a smart retirement pickPrice Action & Technical Pattern Recognition Alerts - baoquankhu1.vn
PepGen falls 20% despite earnings beat on FDA hold concerns By Investing.com - Investing.com Nigeria
Commodore Capital discloses 5.1% stake in PepGen (PEPG) - Stock Titan
PepGen CEO McArthur sells $32875 in shares By Investing.com - Investing.com Nigeria
FDA places partial clinical hold on PepGen’s DM1 trial - Investing.com Nigeria
PepGen unveils new research at MDA2026 poster session - Traders Union
Research Analysts Offer Predictions for PepGen Q1 Earnings - MarketBeat
Profit Review: Can PepGen Inc. stock double in the next year2026 Short Interest & Stepwise Trade Execution Plans - baoquankhu1.vn
Aug Momentum: What are the analyst revisions for NEOVIs PepGen Inc stock a good investment in YEARTrade Entry Summary & Short-Term Trading Alerts - baoquankhu1.vn
PepGen CEO McArthur sells $32875 in shares - Investing.com
Surprises Report: How does PepGen Inc correlate with NasdaqJuly 2025 PreEarnings & AI Driven Stock Reports - baoquankhu1.vn
PepGen (PEPG) CFO’s 2,084-share automatic sale covers RSU tax withholding - Stock Titan
PepGen (PEPG) CEO share sale covers RSU tax withholding obligations - Stock Titan
Grocery Outlet posts downbeat Q4 earnings, joins SES AI, PepGen and other big stocks moving lower in Thursday's pre-market session - MSN
Grocery Outlet Posts Downbeat Q4 Earnings, Joins SES AI, PepGen And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Sahm
PepGen Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - wjfw.com
PepGen Inc. Shareholders Are Encouraged to Reach Out to - GlobeNewswire
FDA curtails Pepgen’s Freedom2 operate in DM1 - bioworld.com
PepGen Still On Track For PGN-EDODM1 Readouts Despite FDA Partial Hold - Citeline News & Insights
PepGen: Stock Slides On FDA Study HoldI'm Firmly On The Sidelines (NASDAQ:PEPG) - Seeking Alpha
PepGen muscular dystrophy drug gets ‘surprise’ hold from FDA - BioPharma Dive
Stifel reiterates Buy on PepGen stock amid partial clinical hold By Investing.com - Investing.com India
Stifel reiterates Buy on PepGen stock amid partial clinical hold - Investing.com Nigeria
PepGen: Clinical and Safety Uncertainties, FDA Partial Hold, and Valuation Gap Support Underperform Rating - TipRanks
PepGen stock slides on FDA partial hold (PEPG:NASDAQ) - Seeking Alpha
PepGen Updates EDO Platform and DM1 Program Outlook - TipRanks
PepGen falls 20% despite earnings beat on FDA hold concerns - Investing.com India
Why Is PepGen Stock Falling Thursday?PepGen (NASDAQ:PEPG) - Benzinga
FDA places partial clinical hold on PepGen’s DM1 trial By Investing.com - Investing.com Canada
US FDA puts partial clinical hold on PepGen’s muscle disease drug trial - 1470 & 100.3 WMBD
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights - PharmiWeb.com
PepGen Announces Regulatory Updates on FREEDOM2 - pharmiweb.com
Pepgen Inc (PEPG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):